Acute Circulatory Failure
18
1
2
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
1 terminated out of 18 trials
91.7%
+5.2% vs benchmark
11%
2 trials in Phase 3/4
0%
0 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (18)
Prediction of Fluid Responsiveness Using the Femoral Vein-to-Artery Diameter Ratio
Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy
Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study
Early Versus Differed Arterial Catheterization in Critically Ill Patients With Acute Circulatory Failure:
Assessment of Agreement Between Two Measurement Methods of Left Ventricular Outflow Tract (LVOT) Velocity Time Integral (VTI)
Systems Analysis of Antigen Presenting Cells in Human Sepsis
Peripheral Tissue Perfusion in Intensive Care
Second Generation DICART Prototype Validation
Concordance Study of Therapeutic Decision-making in Patients With Shock Based on Hemodynamic Monitoring
Subclavian Vein Diameter Variations to Assess Vascular Filling
Applicability of Fluid Responsiveness Indices in Circulatory Failure (AFRIC Study) Study Project
Changes in PPV Induced by PLR Test to Predict Fluid Responsiveness in ICU
Hemodynamic Characteristics of Patients With SARS-CoV-2
Microcirculatory Effects of Methylene Blue
Time Course Evolution of Cardiac Output
FLOTRAC/VIGILEO in Acute Circulatory Failure
Evaluation of Doppler Flow From the Femoral Artery as a Reflection of Cardiac Flow in a Vascular Fluid Test
Central Venous Pressure Change With Volume Challenge in Patients With Hemodynamic Instability